Nucleic Acids Research Laboratory, CSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi -110007, India.
Nucleic Acids Research Laboratory, CSIR-Institute of Genomics and Integrative Biology, Mall Road, Delhi -110007, India.
Colloids Surf B Biointerfaces. 2018 Jan 1;161:403-412. doi: 10.1016/j.colsurfb.2017.10.063. Epub 2017 Oct 26.
Efficient delivery of DNA to cells is the primary concern to address the objective of gene therapy. Many attempts have been made to develop polymeric carriers for gene delivery. To have an efficient carrier, it is vital to understand the properties of the vector for better stability, transfection efficiency and minimal toxicity. Branched polyethylenimine (bPEI) has been considered as the 'gold standard' for gene delivery but suffers a major drawback of exhibiting high cytotoxicity. Here, we have attempted to develop a mussel-derived polymer, polydopamine (PDA), conjugated polyethylenimine nanoparticles in such a way that the toxic nature of bPEI is suppressed by the conversion of free primary amine groups to secondary and tertiary amines. Keeping the amount of PDA fixed, varying amounts of bPEIs of different molecular weights (25, 10 and 1.8kDa) were conjugated via Michael addition and/or Schiff base. A trend in hydrodynamic size of the conjugated nanoparticles was observed in the range from 160 to 300nm and zeta potential from +12-30mV in the projected three series, viz., (i) PDA-bPEI, PDA-bPEI, PDA-bPEI; (ii) PDA-bPEI, PDA-bPEI, PDA-bPEI; and (iii) PDA-bPEI, PDA-bPEI, PDA-bPEI. A visible trend in the DNA condensation ability and buffering capacity was also noticed. Further, cell cytotoxicity assays revealed that pDNA complexes of PDA-bPEI nanoparticles were non-toxic to mammalian cells and these complexes exhibited several folds higher transfection efficiency than the complexes of native bPEIs as demonstrated by fluorescence measurements and flow cytometry. Altogether, the results advocate the promising potential of these conjugated nanoparticles for future in vivo applications.
将 DNA 有效递送至细胞是实现基因治疗目标的首要关注点。人们已经尝试了许多方法来开发用于基因递送的聚合物载体。为了获得高效的载体,了解载体的特性对于更好的稳定性、转染效率和最小毒性至关重要。支化聚乙烯亚胺(bPEI)已被认为是基因递送的“金标准”,但它存在一个主要缺点,即表现出高细胞毒性。在这里,我们试图开发一种贻贝类聚合物,聚多巴胺(PDA),通过迈克尔加成和/或席夫碱将其与聚乙烯亚胺(PEI)偶联,从而将 bPEI 中的游离伯胺基转化为仲胺和叔胺,从而抑制其毒性。保持 PDA 的用量不变,通过迈克尔加成和/或席夫碱将不同分子量(25、10 和 1.8kDa)的 bPEI 以不同的量偶联。在所提出的三个系列中,观察到偶联纳米粒子的水动力粒径在 160 至 300nm 范围内,zeta 电位在+12-30mV 范围内呈趋势,即:(i)PDA-bPEI、PDA-bPEI、PDA-bPEI;(ii)PDA-bPEI、PDA-bPEI、PDA-bPEI;和(iii)PDA-bPEI、PDA-bPEI、PDA-bPEI。还注意到 DNA 凝聚能力和缓冲能力的明显趋势。此外,细胞毒性测定表明,PDA-bPEI 纳米粒子的 pDNA 复合物对哺乳动物细胞无毒,并且这些复合物的转染效率比天然 bPEIs 的复合物高几个数量级,如荧光测量和流式细胞术所示。总之,这些结果表明这些偶联纳米粒子具有用于未来体内应用的有前途的潜力。